Home › US companies › Tenet Healthcare

Tenet Healthcare

THC · NYSE · Services-General Medical & Surgical Hospitals, NEC
Insider buys (12 months)
0
Insider sales (12 months)
$71.2M
8-K reports (12 months)
14
Tracked investors holding
1

At a glance

Tenet Healthcare reported 2025 revenue of $21.31B, up 3.1% from $20.68B in 2024. Over 4 years since 2021 ($19.48B), that is growth of about 2.3% a year. Operating margin was 16.5%, up from 14.7% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 13 insiders reported 0 open-market purchases and 22 sales ($71.2M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $27.6M by CEO Saumya Sutaria on Aug 26, 2026.

Tenet Healthcare filed 14 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), material agreement (3), new financial obligation (3) and officer or director change (3). The latest officer or director change was reported on Apr 10, 2026. It reported a material agreement or a completed acquisition or disposal 3 times.

1 of the 20 investors tracked here held Tenet Healthcare at the last quarter end, worth $7.9M combined. It is the largest weight for Bridgewater Associates (0% of its portfolio). Added: Bridgewater Associates.

Annual results

2021
Revenue $19.48B
Op. $2.87B
2022
Revenue $19.17B
Op. $2.33B
2023
Revenue $20.56B
Op. $2.51B
2024
Revenue $20.68B
Op. $5.96B
2025
Revenue $21.31B
Op. $3.51B
RevenueOperating income (or net income)SEC XBRL annual filings, fiscal years mapped to calendar years
Year20212022202320242025
Net income$1.48B$1B$1.31B$4.06B$2.37B
Diluted EPS$8.42$3.79$5.71$32.70$15.49

Fiscal year ends Dec 31 · incorporated in NV

Tracked investors holding (13F)

Bridgewater AssociatesAdded$7.9M · 0.0% · held 8 quarters

Weight is the share of each investor's portfolio, as of the quarter end.

Current reports (8-K, last 12 months)

Insider open-market trades (last 12 months)

Source: SEC EDGAR. How figures are combined